T2 Biosystems Raises $15 Million

T2 Biosystems Inc., a Cambridge, Mass.-based developer of portable medical diagnostic products that combine nanotech and miniaturized magnetic resonance technology, has raised $15 million in Series C funding. Physic Ventures led the round, and was joined by Arcus Ventures, RA Capital, Camros Capital, WS Investments and return backers Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners and Partners Healthcare. The company previously raised just over $21 million.

North AmericaUSBriefs